Baxter (BAX) Tops Q3 EPS by 9c; cuts FY forecast

Baxter (NYSE: BAX) reported Q3 EPS of $0.69, $0.09 better than the analyst estimate of $0.60. Revenue for the quarter came in at $2.84 billion versus the consensus estimate of $2.88 billion.

GUIDANCE:

Baxter sees Q4 2025 EPS of $0.52-$0.57, versus the consensus of $0.60.

Baxter sees FY2025 EPS of $2.35-$2.40, versus the consensus of $2.44.

For earnings history and earnings-related data on Baxter (BAX) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• AI/ML Innovations plans $2M private placement on the CSE